INSULIN ASPART and VOMITING

Overview

VOMITING is the #8 most commonly reported adverse reaction for INSULIN ASPART, manufactured by Novo Nordisk. There are 2,385 FDA adverse event reports linking INSULIN ASPART to VOMITING. This represents approximately 2.0% of all 120,218 adverse event reports for this drug.

Patients taking INSULIN ASPART who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

VOMITING is a less commonly reported adverse event for INSULIN ASPART, but still significant enough to appear in the safety profile.

Other Side Effects of INSULIN ASPART

In addition to vomiting, the following adverse reactions have been reported for INSULIN ASPART:

• BLOOD GLUCOSE INCREASED — 10,428 reports
• NAUSEA — 3,722 reports
• BLOOD GLUCOSE DECREASED — 3,346 reports
• DRUG INEFFECTIVE — 3,286 reports
• FATIGUE — 2,664 reports
• DYSPNOEA — 2,555 reports
• DIARRHOEA — 2,541 reports
• DIZZINESS — 2,014 reports
• OFF LABEL USE — 1,971 reports
• WEIGHT DECREASED — 1,844 reports

Other Drugs Associated with VOMITING

The following drugs have also been linked to vomiting in FDA adverse event reports:

Does INSULIN ASPART cause VOMITING?

VOMITING has been reported as an adverse event in 2,385 FDA reports for INSULIN ASPART. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is VOMITING with INSULIN ASPART?

VOMITING accounts for approximately 2.0% of all adverse event reports for INSULIN ASPART, making it a notable side effect.

What should I do if I experience VOMITING while taking INSULIN ASPART?

If you experience vomiting while taking INSULIN ASPART, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages